Education
About Us
Working with TipRanks
Follow Us
Dianthus Therapeutics (DNTH)
NASDAQ:DNTH
Dianthus Therapeutics (DNTH) Ownership Overview
<0.01% Insiders
14.53% Mutual Funds
52.87% Other Institutional Investors
6.27% ETFs
26.32% Public Companies and
Individual Investors
The ownership structure of Dianthus Therapeutics (DNTH) stock is a mix of institutional, retail, and individual investors. Approximately 73.67% of the company’s stock is owned by Institutional Investors, <0.01% is owned by Insiders, and 26.32% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Sep 30, 2025 | xxxxxxxxxxxxx | $368906 | |
Sep 30, 2025 | xxxxxxxxxxxxx | $1680166 | |
Sep 30, 2025 | xxxxxxxxxxxxx | $130137965 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,307,191 | Institution | 7.71% | 135,098,752 | |
| 2,866,733 | Institution | 6.69% | 117,106,043 | |
| 1,555,707 | Institution | 3.63% | 63,550,631 | |
| 1,458,168 | Institution | 3.40% | 59,566,163 | |
| 1,260,090 | Institution | 2.94% | 51,474,677 | |
| 789,759 | Institution | 1.84% | 32,261,655 | |
| 628,097 | Institution | 1.46% | 25,657,762 | |
| 614,735 | Institution | 1.43% | 25,111,925 | |
| 509,518 | Institution | 1.19% | 20,813,810 | |
| 449,606 | Institution | 1.05% | 18,366,405 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,555,707 | Institution | 3.63% | 63,550,631 | |
| 1,260,090 | Institution | 2.94% | 51,474,677 | |
| 614,735 | Institution | 1.43% | 25,111,925 | |
| 509,518 | Institution | 1.19% | 20,813,810 | |
| 449,606 | Institution | 1.05% | 18,366,405 | |
| 444,962 | Institution | 1.04% | 18,176,698 | |
| 328,418 | Institution | 0.77% | 13,415,875 | |
| 260,039 | Institution | 0.61% | 10,622,593 | |
| 222,153 | Institution | 0.52% | 9,074,950 | |
| 151,220 | Institution | 0.35% | 6,177,337 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,034,688 | Institution | 2.41% | 40,714,973 | |
| 401,236 | Institution | 0.94% | 14,243,878 | |
| 285,697 | Institution | 0.67% | 11,242,177 | |
| 240,244 | Institution | 0.56% | 8,528,662 | |
| 128,560 | Institution | 0.30% | 4,563,880 | |
| 126,526 | Institution | 0.30% | 4,491,673 | |
| 78,255 | Institution | 0.18% | 3,079,334 | |
| 63,021 | Institution | 0.15% | 2,237,246 | |
| 39,565 | Institution | 0.09% | 1,404,558 | |
| 30,589 | Institution | 0.07% | 1,249,561 |
FAQ
Who Owns Dianthus Therapeutics (DNTH)?
According to the latest TipRanks data, approximately 52.87% of the company's stock is held by institutional investors, <0.01% is held by insiders, and 26.32% is held by retail investors.
What percentage of Dianthus Therapeutics (DNTH) stock is held by institutional investors?
According to the latest TipRanks data, approximately 52.87% of Dianthus Therapeutics (DNTH) stock is held by institutional investors.
What percentage of Dianthus Therapeutics (DNTH) stock is held by retail investors?
According to the latest TipRanks data, approximately 26.32% of Dianthus Therapeutics (DNTH) stock is held by retail investors.
Who owns the most shares of Dianthus Therapeutics (DNTH)?
Peter Harwin owns the most shares of Dianthus Therapeutics (DNTH).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.